Gan Li Pharmaceutical (603087.SH) shareholders, directors and senior management plan to reduce their holdings in the company

According to the Zhitong Finance App, Ganli Pharmaceutical (603087.SH) issued an announcement. Within 3 months after 15 trading days from the date of publication of the announcement, Xute Hongda plans to reduce its holdings by no more than 3.395 million shares through centralized bidding transactions, that is, no more than 0.57% of the company's total share capital. Jiao Jiao plans to reduce the number of shares held by no more than 67,500 shares through centralized bidding, that is, no more than 25% of the company's shares he holds and no more than 0.0112% of the company's total share capital. Sun Cheng plans to reduce the number of shares held by no more than 20,000 shares through centralized bidding, that is, no more than 3.77% of the company's shares he holds and no more than 0.0033% of the company's total share capital.